Reports on the announcement of a deal by Abbot Park, Illinois-based Abbott Laboratories Inc. (ALI) and Durham, North Carolina-based Triangle Pharmaceuticals Inc. (TPI) that claimed to expands the antiviral portfolio of ALI. Ownership of two HIV protease inhibitors by ALI; Possession of nucleoside and non-nucleoside reverse transcriptase inhibitors for the treatment of HIV and HBV by TPI.